We ensure that as many eligible patients as possible are treated with an adequately reimbursed new product. Our mission drives us forward.
Who we are
SKC is a strategic consultancy focused on the increasingly challenging market access environment of innovative drug products. We support the successful market access both on a strategic and an operational level. For more than 15 years, our highly experienced team has been supporting our clients in solving their strategically complex questions.
The specific backgrounds of our colleagues in the field of Health Economics, Social Sciences, Medicine or Pharmacy contribute to fulfilling this mission.
Who are our clients
We are partners of internationally operating pharma-, biotech and medtech companies, as well as of investors, whom we support as sparring partners, or whom we operationally guide through the entire market access process. As we enjoy facing strategic challenges, we particularly manage projects for orphan drug products, for ATMPs and for products which set new therapy standards.
How we work
Our systemic approach and our extensive network with clinical medicine and science allow us to place the patient in the center. We always start of by answering the question: what does the clinical reality look like? Our clients value or hands-on mindset and our custom-made project approach. We are strategic sparring partner and focused, agile implementer – depending on our individual client's need. All our projects have one thing in common though. We always think from the end and anticipate all the challenges at the beginning.
We are enthusiastically committed to solving demanding situations. We are the Market Access Special Forces.